Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.
Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.
Acri.Tec generated sales revenues in the 2006 financial year of 15.4 million. The enterprise value calculated for the company totals 24 million and has to be reduced by the net financial debt at the closing date in order to determine the final purchase price.
Carl Zeiss will acquire all Acri.Tec shares against a cash settlement. The transaction is subject to approval by the German anti-trust authority but, once this approval has been given, the acquisition is expected to be closed during October 2007.
COPHy 2023: Restorative therapies and the path to them
March 24th 2023In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
APAO 2023: Keralink Trial and efficacy safety of corneal cross-linking for children with Keratoconus
February 25th 2023The Keralink Trial was the first randomized clinical trial that tested the hypothesis that corneal cross-linking (CXL) might decrease keratoconus progression in children compared with the use of spectacles or contact lenses.
2 Clarke Drive
Cranbury, NJ 08512